Haemonetics | HAE - Cash And Equivalent


Haemonetics reported $296.43M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Avanos Medical USD 70.5M 19.8M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.26B 459.13M Sep/2025
Globus Medical USD 229.45M 231.82M Jun/2025
Haemonetics USD 296.43M 3.53M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
ICU Medical USD 300.02M 10.32M Jun/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Merit Medical Systems USD 392.46M 50.64M Sep/2025
Neogen USD 145.34M 6.46M Sep/2025
Quidel USD 98.1M 53.6M Sep/2025
ResMed USD 1.42B 33.22M Dec/2025
STAAR Surgical USD 176.16M 9.02M Sep/2025
Steris USD 319.2M 39.5M Sep/2025
Stryker USD 3.26B 881M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
Terumo JPY 204.29B 17.58B Jun/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
US Physical Therapy USD 31.1M 2.98M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025